AstraZeneca Canada Inc. reported 4 lobbying communications with federal officials between Aug 11, 2026 and Aug 28, 2026.
Officials contacted: Varun Srivatsan (Director of Policy) ×2; Stephanie Tanton (Assistance Deputy Minister); Olesia Bissett (Analyst); Mackenzy Metcalfe (Policy Advisor); Kaili Levesque (ADM, ISED Deputy to Secretary of State); Jean-Philippe Arseneau (Chief of Staff).
On the agenda: Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations; Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes; Engage with Canadian government officials to discuss and provide input on Canada’s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry.
